You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Pharma & Healthcare

Global Breast Cancer Predictive Genetic Testing Market Professional Research Report 2021-2027

Market Analysis and Insights: Global Breast Cancer Predictive Genetic Testing Market
The research report studies the Breast Cancer Predictive Genetic Testing market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Breast Cancer Predictive Genetic Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Breast Cancer Predictive Genetic Testing Scope and Segment
The global Breast Cancer Predictive Genetic Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Breast Cancer Predictive Genetic Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
by Type, the market is primarily split into
High Penetrant Genes
Intermediate Penetrant Genes
Low Penetrant Genes
by Application, this report covers the following segments
Global Breast Cancer Predictive Genetic Testing market: regional analysis, the major regions covered in the report are:
North America
United States
Rest of Europe
South Korea
Southeast Asia
Rest of Asia-Pacific
Latin America
Middle East & Africa
Saudi Arabia
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Breast Cancer Predictive Genetic Testing key players in this market include:
Thermo Fisher Scientific
Quest Diagnostics
Myriad Genetics
Iverson Genetics
Cancer Genetics
OncoCyte Corporation
1 Market Overview of Breast Cancer Predictive Genetic Testing
1.1 Breast Cancer Predictive Genetic Testing Market Overview
1.1.1 Breast Cancer Predictive Genetic Testing Product Scope
1.1.2 Breast Cancer Predictive Genetic Testing Market Status and Outlook
1.2 Global Breast Cancer Predictive Genetic Testing Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global Breast Cancer Predictive Genetic Testing Market Size by Region (2016-2027)
1.4 Global Breast Cancer Predictive Genetic Testing Historic Market Size by Region (2016-2021)
1.5 Global Breast Cancer Predictive Genetic Testing Market Size Forecast by Region (2022-2027)
1.6 Key Regions, Breast Cancer Predictive Genetic Testing Market Size (2016-2027)
1.6.1 North America Breast Cancer Predictive Genetic Testing Market Size (2016-2027)
1.6.2 Europe Breast Cancer Predictive Genetic Testing Market Size (2016-2027)
1.6.3 Asia-Pacific Breast Cancer Predictive Genetic Testing Market Size (2016-2027)
1.6.4 Latin America Breast Cancer Predictive Genetic Testing Market Size (2016-2027)
1.6.5 Middle East & Africa Breast Cancer Predictive Genetic Testing Market Size (2016-2027)

2 Breast Cancer Predictive Genetic Testing Market Overview by Type
2.1 Global Breast Cancer Predictive Genetic Testing Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global Breast Cancer Predictive Genetic Testing Historic Market Size by Type (2016-2021)
2.3 Global Breast Cancer Predictive Genetic Testing Forecasted Market Size by Type (2022-2027)
2.4 High Penetrant Genes
2.5 Intermediate Penetrant Genes
2.6 Low Penetrant Genes

3 Breast Cancer Predictive Genetic Testing Market Overview by Application
3.1 Global Breast Cancer Predictive Genetic Testing Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global Breast Cancer Predictive Genetic Testing Historic Market Size by Application (2016-2021)
3.3 Global Breast Cancer Predictive Genetic Testing Forecasted Market Size by Application (2022-2027)
3.4 Hospitals
3.5 Clinics
3.6 Others

4 Breast Cancer Predictive Genetic Testing Competition Analysis by Players
4.1 Global Breast Cancer Predictive Genetic Testing Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Breast Cancer Predictive Genetic Testing as of 2020)
4.3 Date of Key Players Enter into Breast Cancer Predictive Genetic Testing Market
4.4 Global Top Players Breast Cancer Predictive Genetic Testing Headquarters and Area Served
4.5 Key Players Breast Cancer Predictive Genetic Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Breast Cancer Predictive Genetic Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles and Key Data
5.1 Roche
5.1.1 Roche Profile
5.1.2 Roche Main Business
5.1.3 Roche Breast Cancer Predictive Genetic Testing Products, Services and Solutions
5.1.4 Roche Breast Cancer Predictive Genetic Testing Revenue (US$ Million) & (2016-2021)
5.1.5 Roche Recent Developments
5.2 Thermo Fisher Scientific
5.2.1 Thermo Fisher Scientific Profile
5.2.2 Thermo Fisher Scientific Main Business
5.2.3 Thermo Fisher Scientific Breast Cancer Predictive Genetic Testing Products, Services and Solutions
5.2.4 Thermo Fisher Scientific Breast Cancer Predictive Genetic Testing Revenue (US$ Million) & (2016-2021)
5.2.5 Thermo Fisher Scientific Recent Developments
5.3 PerkinElmer
5.3.1 PerkinElmer Profile
5.3.2 PerkinElmer Main Business
5.3.3 PerkinElmer Breast Cancer Predictive Genetic Testing Products, Services and Solutions
5.3.4 PerkinElmer Breast Cancer Predictive Genetic Testing Revenue (US$ Million) & (2016-2021)
5.3.5 Quest Diagnostics Recent Developments
5.4 Quest Diagnostics
5.4.1 Quest Diagnostics Profile
5.4.2 Quest Diagnostics Main Business
5.4.3 Quest Diagnostics Breast Cancer Predictive Genetic Testing Products, Services and Solutions
5.4.4 Quest Diagnostics Breast Cancer Predictive Genetic Testing Revenue (US$ Million) & (2016-2021)
5.4.5 Quest Diagnostics Recent Developments
5.5 Myriad Genetics
5.5.1 Myriad Genetics Profile
5.5.2 Myriad Genetics Main Business
5.5.3 Myriad Genetics Breast Cancer Predictive Genetic Testing Products, Services and Solutions
5.5.4 Myriad Genetics Breast Cancer Predictive Genetic Testing Revenue (US$ Million) & (2016-2021)
5.5.5 Myriad Genetics Recent Developments
5.6 Iverson Genetics
5.6.1 Iverson Genetics Profile
5.6.2 Iverson Genetics Main Business
5.6.3 Iverson Genetics Breast Cancer Predictive Genetic Testing Products, Services and Solutions
5.6.4 Iverson Genetics Breast Cancer Predictive Genetic Testing Revenue (US$ Million) & (2016-2021)
5.6.5 Iverson Genetics Recent Developments
5.7 Cancer Genetics
5.7.1 Cancer Genetics Profile
5.7.2 Cancer Genetics Main Business
5.7.3 Cancer Genetics Breast Cancer Predictive Genetic Testing Products, Services and Solutions
5.7.4 Cancer Genetics Breast Cancer Predictive Genetic Testing Revenue (US$ Million) & (2016-2021)
5.7.5 Cancer Genetics Recent Developments
5.8 OncoCyte Corporation
5.8.1 OncoCyte Corporation Profile
5.8.2 OncoCyte Corporation Main Business
5.8.3 OncoCyte Corporation Breast Cancer Predictive Genetic Testing Products, Services and Solutions
5.8.4 OncoCyte Corporation Breast Cancer Predictive Genetic Testing Revenue (US$ Million) & (2016-2021)
5.8.5 OncoCyte Corporation Recent Developments
5.9 NeoGenomics
5.9.1 NeoGenomics Profile
5.9.2 NeoGenomics Main Business
5.9.3 NeoGenomics Breast Cancer Predictive Genetic Testing Products, Services and Solutions
5.9.4 NeoGenomics Breast Cancer Predictive Genetic Testing Revenue (US$ Million) & (2016-2021)
5.9.5 NeoGenomics Recent Developments
5.10 Invitae
5.10.1 Invitae Profile
5.10.2 Invitae Main Business
5.10.3 Invitae Breast Cancer Predictive Genetic Testing Products, Services and Solutions
5.10.4 Invitae Breast Cancer Predictive Genetic Testing Revenue (US$ Million) & (2016-2021)
5.10.5 Invitae Recent Developments

6 North America
6.1 North America Breast Cancer Predictive Genetic Testing Market Size by Country (2016-2027)
6.2 United States
6.3 Canada

7 Europe
7.1 Europe Breast Cancer Predictive Genetic Testing Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe

8 Asia-Pacific
8.1 Asia-Pacific Breast Cancer Predictive Genetic Testing Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific

9 Latin America
9.1 Latin America Breast Cancer Predictive Genetic Testing Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America

10 Middle East & Africa
10.1 Middle East & Africa Breast Cancer Predictive Genetic Testing Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa

11 Breast Cancer Predictive Genetic Testing Market Dynamics
11.1 Breast Cancer Predictive Genetic Testing Industry Trends
11.2 Breast Cancer Predictive Genetic Testing Market Drivers
11.3 Breast Cancer Predictive Genetic Testing Market Challenges
11.4 Breast Cancer Predictive Genetic Testing Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
  • PUBLISHED DATE: May, 2021
  • NO OF PAGES: 125